Drug Trials Snapshot: FABHLATA
Summary
FABHALTA is a prescription drug that is a complement factor B inhibitor, indicated for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH).
Description
FABHALTA is a prescription drug that is a complement factor B inhibitor, indicated for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH).
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source